Jefferies Financial Group provided price targets for Fate Therapeutics stock on July 9, 2026.
2 reports, 1 independent
Updated Aug 14
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group provided price targets for Fate Therapeutics stock on July 9, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Fate Therapeutics
a clinical-stage biopharmaceutical company in San Diego, United States
Nothing else this week.
-
Jefferies Financial Group
American financial services company
Related events
- Jefferies Financial Group set a price target for Navitas Semiconductor stock.
- Jefferies Financial Group has set a price target for Post Holdings stock.
- Truist Financial lifted its price target and Jefferies Financial Group reissued a buy rating for Pediatrix Medical Group.
- Jefferies Financial Group increased its price target for Procter & Gamble stock, according to MarketScreener.